Literature DB >> 21196398

Obesity and prostate cancer: collateral damage in the battle of the bulge.

Jean-Alfred Thomas1, Stephen J Freedland.   

Abstract

Prostate cancer is the most common non-cutaneous malignancy diagnosed in US men. With the increasing prevalence of obesity, it is of interest how this condition impacts prostate cancer. However, only recently has the relationship between obesity and prostate cancer been earnestly studied by investigators. Indeed, the relationship between obesity and prostate cancer appears to be complex one. Therefore, we sought to review the most recent and relevant epidemiological data discussing the link between prostate cancer and obesity. In this review, we will discuss both "biological" and "non-biological" means by which obesity may potentially impact prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196398     DOI: 10.2741/s173

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  4 in total

1.  Dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced prostate carcinogenesis in CYP1A-humanized mice.

Authors:  Guangxun Li; Hong Wang; Anna B Liu; Connie Cheung; Kenneth R Reuhl; Maarten C Bosland; Chung S Yang
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-11

2.  Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort.

Authors:  Charnita Zeigler-Johnson; Aaron Hudson; Karen Glanz; Elaine Spangler; Knashawn H Morales
Journal:  BMC Cancer       Date:  2018-11-03       Impact factor: 4.430

3.  Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy.

Authors:  Hiroshi Doi; Fumiko Ishimaru; Masao Tanooka; Hiroyuki Inoue; Soichi Odawara; Yasuhiro Takada; Yasue Niwa; Masayuki Fujiwara; Norihiko Kamikonya; Shingo Yamamoto; Shozo Hirota
Journal:  Oncol Lett       Date:  2013-11-05       Impact factor: 2.967

4.  Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression.

Authors:  Irina Banzola; Chantal Mengus; Stephen Wyler; Tvrko Hudolin; Gabriele Manzella; Alberto Chiarugi; Renzo Boldorini; Giovanni Sais; Tobias S Schmidli; Gabriele Chiffi; Alexander Bachmann; Tullio Sulser; Giulio C Spagnoli; Maurizio Provenzano
Journal:  Front Immunol       Date:  2018-05-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.